OncoCyte Corp
OCX
Delayed Nyse MKT - 12/13 09:12:29 pm
5.95USD
+9.17%
Upcoming events
12/14/17
Benchmark Company, LLC Micro Cap Discovery Conference
Past Events
12/07/17 | 02:00pmSan Antonio Breast Cancer Symposium
11/14/17 | 10:30pmQ3 2017 Earnings Call
11/14/17Q3 2017 Earnings Release
08/14/17 | 10:30pmInterim 2017 Earnings Call
Annual results
Annual results20162017 (e)
Sales
Million $
Released
Forecast
Spread




Operating income (EBITDA)
Million $
Released
Forecast
Spread
-10,8
-10,6
-1,4%

-18,6
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-11,1
-11,0
-1,5%

-19,1
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-11,2
-11,1
-0,77%

-19,5
Net income
Million $
Released
Forecast
Spread
-11,2
-11,1
-0,77%

-19,5
EPS
 $
Released
Forecast
Spread
-0,42
-0,35
-20%

-0,65
Announcement Date02/27/2017
Quarterly / Semiannualy publications
Quarterly resultsQ3
2017
Q4
2017 (e)
Sales
Million $
Released
Forecast
Spread




Operating income (EBITDA)
Million $
Released
Forecast
Spread
-6,68
-3,90
-71%

-4,00
Operating profit (EBIT)
Million $
Released
Forecast
Spread
-6,84
-3,83
-79%

-3,85
Pre-Tax Profit (EBT)
Million $
Released
Forecast
Spread
-6,91
-3,88
-78%

-3,85
Net income
Million $
Released
Forecast
Spread
-6,91
-3,88
-78%

-3,85
EPS
 $
Released
Forecast
Spread
-0,22
-0,13
-73%

-0,13
Announcement Date11/14/2017